Target intelligence / Profile preview

Ribosomal protein L7a pseudogene 82 (RPL7AP82)

Target
RPL7AP82
Molecular classification
Other (Processed pseudogene)
01

Overview

RPL7AP82 (Ribosomal protein L7a pseudogene 82) is classified as a processed pseudogene, meaning it originated by reverse transcription of an mRNA and subsequent integration into the genome, but does not produce a functional protein. Processed pseudogenes such as RPL7AP82 typically lack regulatory elements and do not participate directly in cellular function, although some pseudogenes in general may regulate their parental gene as non-coding RNAs. RPL7AP82 is related to the protein-coding gene RPL7A, which encodes a core component of the large ribosomal 60S subunit, but RPL7AP82 itself does not play a role in ribosome assembly, translation, or known disease pathways[1][3][8][10]. There is no evidence to consider RPL7AP82 a receptor, therapeutic target, enzyme, transporter, or transcription factor. Its primary scientific relevance is as a member of the large family of ribosomal protein pseudogenes present throughout the human genome[1][10].

Other names
RPL7AP82HGNC:55905NCBI Gene:122965338Ensembl:ENSG00000228955

Beyond the preview

Go deeper on Ribosomal protein L7a pseudogene 82 (RPL7AP82).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7a pseudogene 82 (RPL7AP82).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call